No title
Chronic obstructive pulmonary disease (COPD) is currently the third leading cause of death worldwide and for patients with end-stage disease, the only viable treatment is lung transplantation. In order to meet this clinical need, novel approaches of tissue engineering have emerged. 3D bioprinting technologies are one such rapidly evolving approach and show promising results in terms of biocompatib
